FTC Concerns Over Bristol-Myers Deal Raise Questions

FTC Concerns Over Bristol-Myers Deal Raise Questions


Law360
By: George Wolfe

Law360 published an article by antitrust and competition associate George L. Wolfe which discusses the Federal Trade Commission's concerns regarding Bristol-Myers Squibb Co.'s proposed acquisition of Celgene Corp. for approximately US$74 billion.

Additional Information
publications-detail.inc